Beijing conference puts traditional medicine, evidence, and regulation on the same stage
The World Conference on Traditional Medicine 2026 closed in Beijing with a slate of policy and collaboration measures that place traditional medicine squarely inside WHO’s broader health agenda. The meeting produced the Beijing Initiative on the Conservation and Sustainable Use of Traditional Medicinal Plant Resources, advanced the New-Era Shennong Herbal Project, and released a report on artificial intelligence in traditional medicine development. It also marked the launch of the Global Alliance for Traditional and Integrative Medicine, a new vehicle for scientific cooperation across borders.
The scope of the meeting was wide, but the organizing logic was consistent: traditional medicine was framed not as a parallel track to modern care, but as a field that now has to meet the same demands for evidence, regulation, quality, and system integration. That framing came through repeatedly in the opening and closing sessions, where speakers emphasized science, technology, and international collaboration as the tools that will determine whether traditional systems can be used safely and credibly at scale.
A call for research, quality control, and shared standards
WHO Director-General Dr Tedros Adhanom Ghebreyesus drew the sharpest line in the policy debate. “This is not a choice between tradition and science,” he said in a video message. “It is about bringing knowledge systems together through research, innovation, regulation and quality assurance. We need stronger evidence on what works, for whom, and under what conditions.”
The message was direct. Traditional medicine cannot move through contemporary health systems on cultural legitimacy alone.
That challenge runs through every part of the field, from plant sourcing and product consistency to clinical evaluation and drug regulation. A remedy can be rooted in centuries of practice and still fail the basic tests required for safe use in modern care if its ingredients are poorly characterized, its preparation is inconsistent, or its effects are not measured against clinically meaningful outcomes. The conference agenda reflected that reality by placing evidence generation and regulatory control alongside conservation and innovation.
Dr Saia Ma’u Piukala, WHO Regional Director for the Western Pacific, connected the meeting to the WHO Global Strategy on Traditional Medicine 2025–2034, with its emphasis on integrating traditional medicine into mainstream health systems. The strategy’s four objectives—strengthening evidence, ensuring safety through regulation, integrating traditional, complementary and integrative medicine into health systems, and realizing value across sectors—were repeatedly used as the organizing frame for the conference program.
Medicinal plant conservation moved from background issue to policy priority
One of the most concrete outcomes was the adoption of the Beijing Initiative on the Conservation and Sustainable Use of Traditional Medicinal Plant Resources. The initiative signals that the future of traditional medicine depends not only on clinical credibility but also on ecological stewardship. Medicinal plants are the raw material for many traditional systems, and supply-chain pressure, habitat loss, and unsustainable harvesting can quickly become health-system problems when access, purity, and continuity of supply are threatened.
The focus on conservation was paired with the New-Era Shennong Herbal Project, which points to ongoing efforts to organize botanical knowledge, research, and development around traditional Chinese medicine. In practical terms, conservation and innovation cannot be separated. Without stable plant resources, there is no reliable manufacturing base. Without rigorous characterization, there is no credible route to standardization or evaluation.
This is where environmental policy and clinical safety meet. The conference did not treat plant conservation as a symbolic add-on; it positioned resource stewardship as a prerequisite for long-term development in traditional medicine.
Artificial intelligence enters traditional medicine development
Another major outcome was the publication of the Report on artificial intelligence empowering global traditional medicine development (2026). The report fits neatly into the conference theme, Technology Empowerment and Integrated Development: Advancing Traditional Medicine for All. AI has obvious appeal in a field that depends on large bodies of historical text, pattern recognition, formulation data, and cross-system comparison. It can support literature synthesis, signal detection, and the organization of complex knowledge sets that were previously difficult to analyze at scale.
The clinical promise is real, but so are the constraints. AI tools are only as useful as the data they are trained on, and traditional medicine data often vary widely in quality, terminology, and standardization. If the underlying records are inconsistent, algorithms can amplify noise as easily as they identify meaningful patterns. The conference’s emphasis on evidence, regulation, and quality assurance matters here because digital tools do not solve credibility problems on their own; they magnify the need for structured, defensible inputs.
A new alliance aims to link institutions across borders
The establishment of the Global Alliance for Traditional and Integrative Medicine (GATIM) was presented as a mechanism for international scientific collaboration. In a field that often develops within distinct national or regional traditions, that kind of coordination can be difficult to achieve. GATIM appears designed to create a common platform for researchers, policymakers, regulators, and health institutions that want to compare methods, exchange evidence, and align standards.
The conference’s scale suggests there is already substantial interest in that kind of platform. Nearly 2,000 participants from 103 countries and areas attended, including 16 ministerial-level health officials. More than 150 high-level speeches and reports were delivered over the two-day meeting. The program covered integration into health systems, evidence-based development, drug regulation, and the use of artificial intelligence in traditional medicine.
Beijing framed traditional medicine as a systems question, not a slogan
Chinese Premier Li Qiang opened the conference by describing traditional medicine as a unique force in safeguarding human health and advancing civilization. He called for deeper international cooperation, better use of global traditional medicine resources, and more support for science and technology in the field. He also said China would promote the digital and intelligent transformation of Traditional Chinese Medicine and encourage participation from Chinese and foreign research institutions and enterprises.
Those remarks reflect a broader policy direction in which traditional medicine is no longer discussed only in heritage terms. It is being linked to innovation, service expansion, cross-border collaboration, and health-system planning. WHO’s participation as co-sponsor gave the meeting added institutional weight, especially because the conference was positioned within the WHO Global Traditional Medicine Strategy 2025–2034.
The unanswered question is not whether traditional medicine will remain part of global health discussions; it clearly will. The harder issue is how quickly the field can produce standardized evidence, enforce quality, and protect plant resources while scaling up digital tools and international partnerships. The Beijing meeting supplied a framework for that work, but the clinical value of the commitments made there will depend on whether they translate into measurable research outputs, regulatory action, and reproducible health-system practice.